Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.3%

2 terminated/withdrawn out of 88 trials

Success Rate

89.5%

+3.0% vs industry average

Late-Stage Pipeline

20%

18 trials in Phase 3/4

Results Transparency

18%

3 of 17 completed trials have results

Key Signals

30 recruiting3 with results

Enrollment Performance

Analytics

N/A

22(37.9%)

Phase 4

15(25.9%)

Phase 2

8(13.8%)

Early Phase 1

6(10.3%)

Phase 1

4(6.9%)

Phase 3

3(5.2%)

58Total

N/A(22)

Phase 4(15)

Phase 2(8)

Early Phase 1(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (88)

Showing 20 of 88 trials

NCT07576543Phase 4Not Yet Recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Role: collaborator

NCT07576517Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Role: collaborator

NCT07095023Not ApplicableRecruiting

Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

Role: collaborator

NCT06140992Recruiting

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Role: collaborator

NCT07532928Enrolling By Invitation

A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data

Role: collaborator

NCT06887881Not ApplicableRecruiting

PIMS vs PGT-A in Infertile PCOS Patients

Role: collaborator

NCT07504445Early Phase 1Recruiting

Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors

Role: lead

NCT07110428Not ApplicableEnrolling By Invitation

Supraglottic Jet Oxygenation Ventilation During Hysteroscopic Surgery

Role: lead

NCT07377916Not ApplicableNot Yet Recruiting

Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLC

Role: collaborator

NCT07374614Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Role: lead

NCT05061342Recruiting

Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer Patients

Role: collaborator

NCT07349498Recruiting

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT07294989Recruiting

The Effective Blood Concentration of Ciprofol

Role: lead

NCT06643858Enrolling By Invitation

Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)

Role: collaborator

NCT07004686Not ApplicableRecruiting

Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in Patients

Role: lead

NCT04339166Not ApplicableCompleted

Embryo Selection by Noninvasive Preimplantation Genetic Test

Role: collaborator

NCT07002723Not ApplicableRecruiting

Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality

Role: lead

NCT06843681Phase 2Enrolling By Invitation

Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

Role: collaborator

NCT01471808Phase 4Completed

Effects of Different Early Intensive Therapies on Long-term β-cell Function

Role: collaborator

NCT07089173Not ApplicableRecruiting

The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study

Role: lead